Cardax (CE) Aktie - CDXI

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

0,000001

Gebot

0,00

Fragen

0,00

Volumen

0,00 Tagesbereich 0,00

0,000001 52-Wochen-Bereich 0,0001

Handelsende

0,000001

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

305

Finanzvolumen

VWAP

Capsugel and Cardax to Collaborate on Development of Proprietary Astaxanthin Products

Collaboration Leverages Capsugel’s Proprietary Lipid-Based Technologies for Potential Development of Consumer Health Products Capsugel and...

Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors

Cardax, Inc. (“Cardax”) (OTCQB:CDXI) announced today the appointment of George W. Bickerstaff, former CFO of Novartis Pharma AG (NYSE:NVS...

Recent Studies Further Demonstrate Astaxanthin’s Potential as a Safe and Effective Anti-Inflammatory

Results Support Cardax Clinical Program Recent studies continue to support astaxanthin’s broad potential in chronic inflammatory disease...

Hawaii Business Features Cardax in 'Hawaii-Born Pill: The Next Wonder Drug?'

Cardax, Inc. (“Cardax” or the “Company”) (OTCQB: CDXI) was featured recently in an in-depth article in the March 2014 issue of Hawaii...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	1.0E-6	1.0E-6	1.0E-6	0	0	CS
12	0	0	1.0E-6	1.0E-6	1.0E-6	305	1.0E-6	CS
26	-9.9E-5	-99	0.0001	0.0001	1.0E-6	411	4.015E-5	CS
52	0	0	1.0E-6	0.0001	1.0E-6	206	4.015E-5	CS
156	-0.799999	-99.999875	0.8	1	1.0E-6	535	0.22091969	CS
260	-6.229999	-99.9999839486	6.23	15	1.0E-6	1242	1.37024524	CS

CDXI - Frequently Asked Questions (FAQ)

What is the current Cardax (CE) share price?

The current share price of Cardax (CE) is US$ 0,000001

What is the 1 year trading range for Cardax (CE) share price?

Cardax (CE) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
DVNCFDanavation Technologies Corporation (CE)	US$ 0,0044 (439.900,00%)	3,68k
STLBSterling Business Solutions Inc (CE)	US$ 0,0002 (19.900,00%)	100
OGNTOrgana Technologies Group Inc (CE)	US$ 0,000167 (16.600,00%)	120
IMTLImage Protect Inc (PK)	US$ 0,0001 (9.900,00%)	1M
REFXFRedflow Ltd (PK)	US$ 0,01 (9.900,00%)	10k
PHRZFPharol SGPA SA (PK)	US$ 0,0001 (-99,75%)	800
VIEWFViewtran Group Inc (CE)	US$ 0,000001 (-99,00%)	500
TTCFQTattooed Chef Inc (CE)	US$ 0,000001 (-99,00%)	1,59k
TMGIMarquie Group Inc (PK)	US$ 0,000001 (-99,00%)	1,7M
DLOCDigital Locations Inc (CE)	US$ 0,000001 (-99,00%)	1,56k
HMBLHUMBL Inc (PK)	US$ 0,0003 (0,00%)	385,08M
TWOHTwo Hands Corporation (PK)	US$ 0,0007 (-50,00%)	301,5M
DPLSDarkPulse Inc (PK)	US$ 0,00045 (-10,00%)	184,93M
MJLBUltrack Systems Inc (PK)	US$ 0,0002 (0,00%)	170,71M
BOMObowmo Inc (PK)	US$ 0,0002 (100,00%)	162,63M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Cardax Inc (CE) (CDXI)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

CDXI Neueste Nachrichten

Capsugel and Cardax to Collaborate on Development of Proprietary Astaxanthin Products

Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors

Recent Studies Further Demonstrate Astaxanthin’s Potential as a Safe and Effective Anti-Inflammatory

Hawaii Business Features Cardax in 'Hawaii-Born Pill: The Next Wonder Drug?'

CDXI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Cardax Inc (CE) (CDXI) Börsenkurse

Cardax Inc (CE) (CDXI)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

CDXI Neueste Nachrichten

Capsugel and Cardax to Collaborate on Development of Proprietary Astaxanthin Products

Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors

Recent Studies Further Demonstrate Astaxanthin’s Potential as a Safe and Effective Anti-Inflammatory

Hawaii Business Features Cardax in 'Hawaii-Born Pill: The Next Wonder Drug?'

CDXI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen